CalciMedica, Inc. (CALC)

CalciMedica Statistics

Total Valuation

CalciMedica has a market cap or net worth of $45.41 million. The enterprise value is $35.95 million.

Market Cap	45.41M
Enterprise Value	35.95M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

CalciMedica has 13.97 million shares outstanding. The number of shares has increased by 64.69% in one year.

Current Share Class	13.97M
Shares Outstanding	13.97M
Shares Change (YoY)	+64.69%
Shares Change (QoQ)	+6.19%
Owned by Insiders (%)	12.05%
Owned by Institutions (%)	12.29%
Float	5.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.44
P/TBV Ratio	7.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.45, with a Debt / Equity ratio of 1.39.

Current Ratio	5.45
Quick Ratio	5.16
Debt / Equity	1.39
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-26.88

Financial Efficiency

Return on equity (ROE) is -209.36% and return on invested capital (ROIC) is -109.99%.

Return on Equity (ROE)	-209.36%
Return on Assets (ROA)	-77.95%
Return on Invested Capital (ROIC)	-109.99%
Return on Capital Employed (ROCE)	-160.39%
Revenue Per Employee	n/a
Profits Per Employee	-$1.49M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.44% in the last 52 weeks. The beta is 1.41, so CalciMedica's price volatility has been higher than the market average.

Beta (5Y)	1.41
52-Week Price Change	-25.44%
50-Day Moving Average	3.05
200-Day Moving Average	2.41
Relative Strength Index (RSI)	56.11
Average Volume (20 Days)	62,199

Short Selling Information

The latest short interest is 71,964, so 0.52% of the outstanding shares have been sold short.

Short Interest	71,964
Short Previous Month	63,199
Short % of Shares Out	0.52%
Short % of Float	1.31%
Short Ratio (days to cover)	1.01

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-25.03M
Pretax Income	-20.87M
Net Income	-20.87M
EBITDA	-24.97M
EBIT	-25.03M
Earnings Per Share (EPS)	-$1.57

Balance Sheet

The company has $17.96 million in cash and $8.50 million in debt, giving a net cash position of $9.46 million or $0.68 per share.

Cash & Cash Equivalents	17.96M
Total Debt	8.50M
Net Cash	9.46M
Net Cash Per Share	$0.68
Equity (Book Value)	6.10M
Book Value Per Share	0.44
Working Capital	15.49M

Cash Flow

In the last 12 months, operating cash flow was -$21.19 million and capital expenditures -$22,000, giving a free cash flow of -$21.21 million.

Operating Cash Flow	-21.19M
Capital Expenditures	-22,000
Free Cash Flow	-21.21M
FCF Per Share	-$1.52

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CalciMedica does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-64.69%
Shareholder Yield	-64.69%
Earnings Yield	-45.97%
FCF Yield	-46.71%

Analyst Forecast

The average price target for CalciMedica is $14.50, which is 346.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.50
Price Target Difference	346.15%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1